ORAL GASTROINTESTINAL DOSAGE FORM DELIVERY SYSTEM OF CANNABINOIDS AND/OR STANDARDIZED MARIJUANA EXTRACTS

An oral gastrointestinal dosage form of cannabinoids and/or standardized marijuana extracts in a self-emulsifying system operable to avoid hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery for promoting lymphatic transport. The oral gastrointestinal dosage form includes: (a) a pharmacologically active form of cannabinoids and/or standardized marijuana extracts; and (b) an oily medium consisting of: (i) one or more triglycerides formed from long chain fatty having from C13 to C24 carbon atoms; (ii) one or more mixed glycerides formed from long chain fatty having from C13 to C24 carbon atoms; and (iii) one or more free fatty acids formed from un-esterified long chain fatty acids having from C13 to C24 carbon atoms; and (c) about 10-60 wt % of a surfactant which promotes self-emulsification.